These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 5465489)

  • 1. [Therapy and prognosis of bladder tumors--result of injection of mitomycin C into the bladder].
    Shida K; Shimasaki J; Takahashi H; Kurihara H; Sato J
    Gan No Rinsho; 1970 Jul; 16(7):737-44. PubMed ID: 5465489
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combination chemotherapy of mitomycin C and cytosine arabinoside in superficial bladder tumors. 1. Evaluation of intravesical infusion therapy].
    Ikeuchi T; Onodera Y; Kai Y
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2145-51. PubMed ID: 6414383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Combination chemotherapy of mitomycin C and cytosine arabinoside in the intravesical treatment for superficial bladder tumors: report 2. Evaluation of prophylactic intravesical infusion therapy].
    Ikeuchi T; Onodera Y; Kai Y
    Gan To Kagaku Ryoho; 1984 Apr; 11(4):858-63. PubMed ID: 6426397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Local mitomycin-C therapy of infiltrating bladder cancer].
    Erdmann WD; Harzmann R; Flüchter SH; Bichler KH
    Fortschr Med; 1984 Aug; 102(29-30):767-71. PubMed ID: 6437950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical studies on intravesical instillation therapy for bladder cancer].
    Yamanaka H; Kaburagi Y; Imai K; Miki M
    Hinyokika Kiyo; 1983 Nov; 29(11):1427-32. PubMed ID: 6428193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microcapsule chemoembolization therapy: a new approach to bladder cancer.
    Kato T
    Prog Clin Biol Res; 1984; 162B():359-63. PubMed ID: 6209723
    [No Abstract]   [Full Text] [Related]  

  • 7. Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim report.
    DeFuria MD; Bracken RB; Johnson DE; Soloway MS; Merrin CE; Morgan LR; Miller HC; Crooke ST
    Cancer Treat Rep; 1980; 64(2-3):225-30. PubMed ID: 7407754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Local chemotherapy of bladder carcinoma with mitomycin (author's transl)].
    Flüchter SH; Harzmann R; Hlobil H; Erdmann W; Bichler KH
    Urologe A; 1982 Jan; 21(1):24-8. PubMed ID: 6805121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Periodic prophylactic bladder instillation (PPI) of mitomycin C].
    Mishina T; Watanabe H; Fujiwara T; Kobayashi T; Maegawa M; Nakao M; Nakagawa S
    Gan To Kagaku Ryoho; 1982 Mar; 9(3):365-71. PubMed ID: 6820896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intracavitary treatment of tumors of the bladder with cytotoxic agent (mitomycin C) and radioactive phosphorus (32P). IV].
    Ogawa H
    Nihon Hinyokika Gakkai Zasshi; 1969 Aug; 60(8):746-55. PubMed ID: 5388929
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Recurrence rate in adjuvant local chemotherapy of bladder cancer with mitomycin C].
    Flüchter SH; Harzmann R; Erdmann D; Bichler KH
    Helv Chir Acta; 1982 Aug; 49(3-4):349-52. PubMed ID: 6813293
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anti-tumor effect of intravesical instillation of mitomycin C combined with cytosine arabinoside].
    Matsuda M; Matsumiya K; Tada Y; Nakano E; Fujioka H; Osafune M; Takaha M; Sonoda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1145-51. PubMed ID: 6441472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination of intra-arterial administration of anticancer agent and hemocarboperfusion in treatment of advanced cancer].
    Yamagata J; Agishi T; Ota K; Shida K; Shibayama K; Yamanaka E; Hata H; Nagata T; Ishigami J; Kamidono S
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2139-44. PubMed ID: 6414382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of combination chemotherapy with cytosine arabinoside in the intravesical treatment of superficial bladder tumors].
    Yoshida O; Miyakawa M; Watanabe H; Mishina T; Kobayashi T; Nakagawa K; Fukuyama T; Ogura K; Ueyama H; Itoh H
    Hinyokika Kiyo; 1983 Mar; 29(3):357-64. PubMed ID: 6233856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C in the treatment of superficial bladder neoplasm.
    Liberti M; De Berardinis E; Perugia G; Gentile V; Rondoni M; Riga T
    Panminerva Med; 1988; 30(1):52-3. PubMed ID: 3138624
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravesical chemical prevention of recurrence of superficial urothelial bladder cancer. Progress report of the Urology Clinic of Mainz University 1975-1981].
    Jacobi GH; Engelmann U; Frohneberg D; Thüroff JW
    Helv Chir Acta; 1982 Aug; 49(3-4):345-8. PubMed ID: 6813292
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic use of mitomycin C in bladder cancer.
    Denis L
    Prog Clin Biol Res; 1984; 162B():113-22. PubMed ID: 6438638
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasms.
    Daskal Y; Soloway MS; DeFuria MD; Crooke ST
    Cancer Res; 1980 Feb; 40(2):261-7. PubMed ID: 7356509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder wall fibrosis following intravesical mitomycin treatment for superficial bladder cancer.
    Katz G; Hackett RL; Wajsman Z
    Urology; 1996 Jun; 47(6):928-9. PubMed ID: 8677595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.